Back to 
JPMORGAN CHASE & CO
JPMORGAN CHASE & CO
QNCX1 quarters
Position history for JPMORGAN CHASE & CO's holdings in QUINCE THERAPEUTICS INC
Yes. JPMorgan Chase holds 2 shares of QNCX (Quince Therapeutics), worth $2, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$2
Current Shares
2
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of QNCX: BALYASNY ASSET MANAGEMENT L.P., MILLENNIUM MANAGEMENT LLC, JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC, UBS Group AG